Home/Filings/4/0000014930-26-000020
4//SEC Filing

MCCLANATHAN JOSEPH W 4

Accession 0000014930-26-000020

CIK 0000014930other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:44 PM ET

Size

5.1 KB

Accession

0000014930-26-000020

Research Summary

AI-generated summary of this filing

Updated

Brunswick (BC) Director Joseph W. McClanathan Receives 934-Share Award

What Happened
Joseph W. McClanathan, a director of Brunswick Corporation, was granted 934 shares on January 30, 2026. The award was reported at $80.22 per share, for a total reported value of $74,925. This transaction is an award/grant (code A) — an acquisition of shares rather than an open-market purchase.

Key Details

  • Transaction date: 2026-01-30; price per share: $80.22; total value: $74,925.
  • Shares acquired: 934 (412 of these are deferred shares deposited into the director’s deferred account; they will be distributed in predetermined installments after the director ceases being a director).
  • Shares owned after transaction: Not specified in the filing.
  • Other holdings note: Beneficial holdings reported include 122 shares acquired via dividend reinvestment in December 2025.
  • Filing date: 2026-02-02 — filed within the required 2-business-day window (timely).

Context
This filing documents an equity award to a director, which is typically part of board compensation. Deferred shares are common for directors and do not mean immediate sale or market activity; they are scheduled for future distribution per the director deferred account terms. As an award (not a sale), the transaction indicates acquisition of stock but should be read as routine compensation unless additional filings or patterns suggest otherwise.

Insider Transaction Report

Form 4
Period: 2026-01-30
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-01-30$80.22/sh+934$74,92526,898 total
Footnotes (2)
  • [F1]412 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
  • [F2]Beneficial holdings include 122 shares acquired pursuant to dividend reinvestment in December 2025.
Signature
By: Power of Attorney For: /s/ Joseph W. McClanathan|2026-02-02

Issuer

BRUNSWICK CORP

CIK 0000014930

Entity typeother

Related Parties

1
  • filerCIK 0001182964

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:44 PM ET
Size
5.1 KB